 | Up a level |
Grünberg, Jürgen; Lindenblatt, Dennis; Dorrer, Holger; Cohrs, Susan; Zhernosekov, Konstantin; Köster, Ulli; Türler, Andreas; Fischer, Eliane; Schibli, Roger (2014). Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model. European journal of nuclear medicine and molecular imaging, 41(10), pp. 1907-1915. Springer 10.1007/s00259-014-2798-3
Müller, Cristina; Fischer, Eliane; Behe, Martin; Köster, Ulli; Dorrer, Holger Johann; Reber, Josefine; Haller, Stephanie; Cohrs, Susan; Blanc, Alain; Grünberg, Jürgen; Bunka, Maruta; Zhernosekov, Konstantin; van der Meulen, Nicholas; Johnston, Karl; Türler, Andreas; Schibli, Roger (2014). Future prospects for SPECT imaging using the radiolanthanide terbium-155 — production and preclinical evaluation in tumor-bearing mice. Nuclear medicine and biology, 41 Suppl, e58-65. Elsevier 10.1016/j.nucmedbio.2013.11.002
Lehenberger, Silvia; Barkhausen, Christoph; Cohrs, Susan; Fischer, Eliane; Grünberg, Jürgen; Hohn, Alexander; Köster, Ulli; Schibli, Roger; Türler, Andreas; Zhernosekov, Konstantin (2011). The low-energy β− and electron emitter 161Tb as an alternative to 177Lu for targeted radionuclide therapy. Nuclear medicine and biology, 38(6), pp. 917-924. Oxford: Elsevier 10.1016/j.nucmedbio.2011.02.007
